MA24269A1 - Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins - Google Patents

Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins

Info

Publication number: MA24269A1
Authority: MA; Morocco
Prior art keywords: cattle; particular against; against respiratory; polynucleotide vaccine; vaccine formula
Prior art date: 1996-07-19

Application number

MA24716A

Other languages

English (en)

French (fr)

Original Assignee

Merial Sas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-19

Filing date

1997-07-16

Publication date

1998-04-01

1997-07-16 Application filed by Merial Sas filed Critical Merial Sas

1998-04-01 Publication of MA24269A1 publication Critical patent/MA24269A1/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/813—Viral vaccine for bovine species, e.g. cattle

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

MA24716A 1996-07-19 1997-07-16 Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins MA24269A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9609403A FR2751229B1 (fr)	1996-07-19	1996-07-19	Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins

Publications (1)

Publication Number	Publication Date
MA24269A1 true MA24269A1 (fr)	1998-04-01

Family

ID=9494497

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA24716A MA24269A1 (fr)	1996-07-19	1997-07-16	Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins

Country Status (29)

Country	Link
US (2)	US6376473B1 (2)
EP (2)	EP1382348B1 (2)
JP (1)	JP2000516200A (2)
AP (1)	AP9701044A0 (2)
AR (1)	AR007862A1 (2)
AT (2)	ATE307607T1 (2)
AU (1)	AU734442B2 (2)
BR (1)	BR9710506A (2)
CA (1)	CA2260855C (2)
CO (1)	CO4700306A1 (2)
CZ (2)	CZ298898B6 (2)
DE (2)	DE69734483T2 (2)
DK (2)	DK0912194T3 (2)
ES (2)	ES2254833T3 (2)
FR (1)	FR2751229B1 (2)
HR (1)	HRP970383A2 (2)
HU (2)	HU225169B1 (2)
ID (1)	ID19513A (2)
IL (2)	IL127703A0 (2)
MA (1)	MA24269A1 (2)
NZ (4)	NZ517686A (2)
PE (1)	PE84699A1 (2)
PL (1)	PL190122B1 (2)
PT (1)	PT912194E (2)
PY (1)	PY970078A (2)
RU (1)	RU2305560C2 (2)
UA (1)	UA70914C2 (2)
WO (1)	WO1998003200A2 (2)
ZA (1)	ZA976283B (2)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2751229B1 (fr) *	1996-07-19	1998-11-27	Rhone Merieux	Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
US7078388B2 (en)	2000-01-21	2006-07-18	Merial	DNA vaccines for farm animals, in particular bovines and porcines
US6852705B2 (en) *	2000-01-21	2005-02-08	Merial	DNA vaccines for farm animals, in particular bovines and porcines
US20040002472A1 (en) *	2000-01-21	2004-01-01	Audonnet Jean-Christophe Francis	Vaccination or immunization using a prime-boost regimen
FR2804028B1 (fr) *	2000-01-21	2004-06-04	Merial Sas	Vaccins adn ameliores pour animaux de rente
US7906311B2 (en)	2002-03-20	2011-03-15	Merial Limited	Cotton rat lung cells for virus culture
EP1606419A1 (en)	2003-03-18	2005-12-21	Quantum Genetics Ireland Limited	Systems and methods for improving protein and milk production of dairy herds
US7468273B2 (en)	2003-05-01	2008-12-23	Meial Limited	Canine GHRH gene, polypeptides and methods of use
US20050214316A1 (en)	2003-11-13	2005-09-29	Brown Thomas P	Methods of characterizing infectious bursal disease virus
MXPA06009452A (es)	2004-02-19	2007-03-15	Univ Alberta	Polimorfismos del promotor de leptin y sus usos.
PT1881845E (pt)	2005-04-25	2010-05-31	Merial Ltd	Vacinas de vírus nipah
US20080241184A1 (en)	2005-08-25	2008-10-02	Jules Maarten Minke	Canine influenza vaccines
EP3147296A1 (en)	2005-11-14	2017-03-29	Merial, Inc.	Gene therapy for renal failure
US7771995B2 (en)	2005-11-14	2010-08-10	Merial Limited	Plasmid encoding human BMP-7
US7862821B2 (en)	2006-06-01	2011-01-04	Merial Limited	Recombinant vaccine against bluetongue virus
UA100692C2 (ru)	2007-05-02	2013-01-25	Мериал Лимитед	Днк-плазмиды, имеющие повышенную экспрессию и стабильность
US20080274137A1 (en) *	2007-05-02	2008-11-06	Jean Christophe Francis Audonnet	DNA plasmids having improved expression and stability
RU2559527C2 (ru)	2008-11-28	2015-08-10	Мериал Лимитед	Рекомбинантная вакцина от птичьего гриппа и её применение
WO2010115133A2 (en)	2009-04-03	2010-10-07	Merial Limited	Newcastle disease virus vectored avian vaccines
CN103260643A (zh)	2009-12-28	2013-08-21	梅里亚有限公司	重组ndv抗原及其用途
CN102947341B (zh)	2010-01-19	2018-07-06	哈佛大学校长及研究员协会	用于病原体检测和治疗的工程化调理素
US20130197612A1 (en)	2010-02-26	2013-08-01	Jack W. Lasersohn	Electromagnetic Radiation Therapy
ES2617743T3 (es)	2010-03-12	2017-06-19	Merial, Inc.	Vacunas recombinantes del virus de la lengua azul y sus utilizaciones
WO2012030720A1 (en)	2010-08-31	2012-03-08	Merial Limited	Newcastle disease virus vectored herpesvirus vaccines
AR084358A1 (es) *	2010-12-27	2013-05-08	Lilly Co Eli	Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
WO2012090073A2 (en)	2010-12-30	2012-07-05	The Netherlands Cancer Institute	Methods and compositions for predicting chemotherapy sensitivity
EP2694678A2 (en)	2011-04-04	2014-02-12	Netherland Cancer Institute	Methods and compositions for predicting resistance to anticancer treatment
US20140296248A1 (en)	2011-04-04	2014-10-02	Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis	Methods and compositions for predicting resistance to anticancer treatment
US9216213B2 (en)	2011-04-20	2015-12-22	Merial, Inc.	Adjuvanted rabies vaccine with improved viscosity profile
HK1200329A1 (en)	2011-04-25	2015-08-07	先进生物学实验室股份有限公司	Truncated hiv envelope proteins (env), methods and compositions related thereto
ES2764079T3 (es)	2011-05-27	2020-06-02	Boehringer Ingelheim Animal Health Usa Inc	Vacunas genéticas contra el virus Hendra y el virus Nipah
CA2837375C (en)	2011-06-01	2019-07-16	Merial Limited	Needle-free administration of prrsv vaccines
WO2013012924A2 (en)	2011-07-18	2013-01-24	President And Fellows Of Harvard College	Engineered microbe-targeting molecules and uses thereof
SI2741740T1 (sl)	2011-08-12	2017-08-31	Merial, Inc.	Vakuumsko konzerviranje bioloških proizvodov, zlasti cepiv
WO2013093629A2 (en)	2011-12-20	2013-06-27	Netherlands Cancer Institute	Modular vaccines, methods and compositions related thereto
WO2013106558A1 (en)	2012-01-10	2013-07-18	Merial Limited	Lipid based adjuvants for dna - plasmid vaccines
EP3466443B1 (en)	2012-02-14	2020-12-16	Boehringer Ingelheim Animal Health USA Inc.	Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom
ES2632429T3 (es)	2012-02-14	2017-09-13	Merial, Inc.	Vacunas subunitarias de rotavirus y procedimientos para la fabricación y utilización de las mismas
WO2013138776A1 (en)	2012-03-16	2013-09-19	Merial Limited	Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
ES2664069T3 (es)	2012-06-13	2018-04-18	Merial, Inc.	Vacunas contra BTV y AHSV de genoma reordenado
MY171498A (en)	2012-08-01	2019-10-15	Bavarian Nordic As	Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine
WO2014164697A1 (en)	2013-03-12	2014-10-09	Merial Limited	Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof
EP2976642A4 (en)	2013-03-15	2016-09-21	Harvard College	METHOD AND COMPOSITIONS FOR IMPROVING THE DETECTION AND / OR RECORDING OF A TARGET UNIT
WO2014190040A1 (en)	2013-05-21	2014-11-27	President And Fellows Of Harvard College	Engineered heme-binding compositions and uses thereof
EP3083658B1 (en)	2013-12-18	2019-05-08	President and Fellows of Harvard College	Crp capture/detection of gram positive bacteria
CA2966191A1 (en)	2014-11-03	2016-05-12	Merial, Inc.	Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
DK3313864T3 (da)	2015-06-23	2021-11-01	Boehringer Ingelheim Animal Health Usa Inc	Rekombinante virusvektorer indeholdende prrsv minor protein og fremgangsmåder til fremstilling og anvendelse deraf
US10435457B2 (en)	2015-08-06	2019-10-08	President And Fellows Of Harvard College	Microbe-binding molecules and uses thereof
WO2017031120A1 (en)	2015-08-20	2017-02-23	Merial, Inc.	Fcv recombinant vaccines and uses thereof
FI3355915T3 (fi)	2015-09-29	2024-01-12	Boehringer Ingelheim Animal Health Usa Inc	Koirien parvoviruksen (CPV) viruksen kaltaisten hiukkasten (VLP) rokotteet ja niiden käytöt
MA42640B1 (fr)	2015-11-23	2021-06-30	Merial Inc	Protéines de fusion de dmdv et e2 et leurs utilisations
TWI760322B (zh)	2016-01-29	2022-04-11	美商百靈佳殷格翰動物保健美國有限公司	重組腺病毒載體裝載之fmdv疫苗及其用途
CN109021081B (zh) *	2018-08-10	2019-06-04	山东大学	一种牛病毒性腹泻病毒样颗粒及其构建方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU611784B2 (en) *	1988-04-22	1991-06-20	Pharmacia & Upjohn Company	Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
AU650040B2 (en) *	1990-07-24	1994-06-09	Uab Research Foundation, The	Methods of use of bovine respiratory syncytial virus recombinant DNA, proteins vaccines, antibodies, and transformed cells
GB9200117D0 (en) *	1992-01-06	1992-02-26	Connaught Lab	Production of recombinant chimeric proteins for vaccine use
CA2136677A1 (en) *	1993-12-29	1995-06-30	Intervet, Inc.	Method of intranasally administering to bovines a trivalent vaccine containing modified live ibrv, pl3v and brsv
ATE475668T1 (de) *	1994-01-27	2010-08-15	Univ Massachusetts Medical	Immunisierung durch impfung von dns transkriptionseinheit
US5541102A (en) *	1994-09-02	1996-07-30	Board Of Regents, University Of Nebraska-Lincoln	Bovine cell line resistant to in vitro infection by bovine viral diarrhea virus and all other known pestiviruses
US6019980A (en) *	1995-06-07	2000-02-01	Connaught Laboratories Limited	Nucleic acid respiratory syncytial virus vaccines
US6060457A (en)	1996-06-20	2000-05-09	Universite De Montreal	DNA plasmid vaccine for immunization of animals against BVDV
FR2751229B1 (fr) *	1996-07-19	1998-11-27	Rhone Merieux	Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
JP5566663B2 (ja) *	2009-11-09	2014-08-06	三菱重工業株式会社	多翼遠心ファンおよびそれを用いた空気調和機

1996
- 1996-07-19 FR FR9609403A patent/FR2751229B1/fr not_active Expired - Lifetime
1997
- 1997-07-06 NZ NZ517686A patent/NZ517686A/xx not_active IP Right Cessation
- 1997-07-06 NZ NZ508939A patent/NZ508939A/en not_active IP Right Cessation
- 1997-07-06 NZ NZ508940A patent/NZ508940A/xx not_active IP Right Cessation
- 1997-07-11 AR ARP970103111A patent/AR007862A1/es active IP Right Grant
- 1997-07-15 HR HR9609403A patent/HRP970383A2/hr not_active Application Discontinuation
- 1997-07-16 IL IL12770397A patent/IL127703A0/xx active IP Right Grant
- 1997-07-16 DK DK97934578T patent/DK0912194T3/da active
- 1997-07-16 EP EP03016996A patent/EP1382348B1/fr not_active Expired - Lifetime
- 1997-07-16 PT PT97934578T patent/PT912194E/pt unknown
- 1997-07-16 ZA ZA976283A patent/ZA976283B/xx unknown
- 1997-07-16 MA MA24716A patent/MA24269A1/fr unknown
- 1997-07-16 JP JP09535655A patent/JP2000516200A/ja active Pending
- 1997-07-16 CZ CZ0017599A patent/CZ298898B6/cs not_active IP Right Cessation
- 1997-07-16 UA UA99020960A patent/UA70914C2/uk unknown
- 1997-07-16 CZ CZ20070776A patent/CZ298915B6/cs not_active IP Right Cessation
- 1997-07-16 PL PL97331236A patent/PL190122B1/pl unknown
- 1997-07-16 HU HU9902791A patent/HU225169B1/hu unknown
- 1997-07-16 DE DE69734483T patent/DE69734483T2/de not_active Expired - Lifetime
- 1997-07-16 WO PCT/FR1997/001325 patent/WO1998003200A2/fr not_active Ceased
- 1997-07-16 AT AT03016996T patent/ATE307607T1/de active
- 1997-07-16 CA CA2260855A patent/CA2260855C/en not_active Expired - Lifetime
- 1997-07-16 BR BR9710506A patent/BR9710506A/pt not_active Application Discontinuation
- 1997-07-16 AT AT97934578T patent/ATE253376T1/de active
- 1997-07-16 DK DK03016996T patent/DK1382348T3/da active
- 1997-07-16 ES ES03016996T patent/ES2254833T3/es not_active Expired - Lifetime
- 1997-07-16 AU AU37735/97A patent/AU734442B2/en not_active Expired
- 1997-07-16 HU HU0500910A patent/HU228353B1/hu unknown
- 1997-07-16 EP EP97934578A patent/EP0912194B1/fr not_active Expired - Lifetime
- 1997-07-16 ES ES97934578T patent/ES2210548T3/es not_active Expired - Lifetime
- 1997-07-16 NZ NZ333751A patent/NZ333751A/en not_active IP Right Cessation
- 1997-07-16 DE DE69725988T patent/DE69725988T2/de not_active Expired - Lifetime
- 1997-07-16 ID IDP972480A patent/ID19513A/id unknown
- 1997-07-17 AP APAP/P/1997/001044A patent/AP9701044A0/en unknown
- 1997-07-18 PY PY199700970078A patent/PY970078A/es unknown
- 1997-07-18 CO CO97040983A patent/CO4700306A1/es unknown
1998
- 1998-01-16 PE PE1998000035A patent/PE84699A1/es not_active Application Discontinuation
- 1998-12-23 IL IL127703A patent/IL127703A/en not_active IP Right Cessation
1999
- 1999-01-15 US US09/232,279 patent/US6376473B1/en not_active Expired - Lifetime
2002
- 2002-02-28 US US10/085,519 patent/US6818628B2/en not_active Expired - Lifetime
- 2002-12-05 RU RU2002132831/13A patent/RU2305560C2/ru active

Also Published As

Publication number	Publication date
UA70914C2 (uk)	2004-11-15
CO4700306A1 (es)	1998-12-29
ATE253376T1 (de)	2003-11-15
AP9701044A0 (en)	1997-07-31
ES2254833T3 (es)	2006-06-16
FR2751229B1 (fr)	1998-11-27
DE69734483D1 (de)	2005-12-01
CZ17599A3 (cs)	1999-06-16
EP1382348A2 (fr)	2004-01-21
NZ517686A (en)	2003-01-31
PL331236A1 (en)	1999-07-05
PL190122B1 (pl)	2005-11-30
DE69725988T2 (de)	2004-11-11
ID19513A (id)	1998-07-16
EP1382348B1 (fr)	2005-10-26
ZA976283B (en)	1999-01-19
IL127703A0 (en)	1999-10-28
WO1998003200A3 (fr)	1998-02-26
RU2305560C2 (ru)	2007-09-10
PY970078A (es)	2001-12-03
WO1998003200A2 (fr)	1998-01-29
EP1382348A3 (fr)	2004-01-28
DE69734483T2 (de)	2006-07-20
ES2210548T3 (es)	2004-07-01
AU3773597A (en)	1998-02-10
DK0912194T3 (da)	2004-03-15
CA2260855C (en)	2012-01-03
CZ298898B6 (cs)	2008-03-05
RU2002132831A (ru)	2005-01-20
NZ333751A (en)	2001-03-30
IL127703A (en)	2006-12-31
HU228353B1 (en)	2013-03-28
HUP9902791A2 (hu)	1999-12-28
CZ298915B6 (cs)	2008-03-12
HU0500910D0 (en)	2005-11-28
FR2751229A1 (fr)	1998-01-23
AR007862A1 (es)	1999-11-24
US20020160018A1 (en)	2002-10-31
JP2000516200A (ja)	2000-12-05
AU734442B2 (en)	2001-06-14
US6376473B1 (en)	2002-04-23
DE69725988D1 (de)	2003-12-11
EP0912194A2 (fr)	1999-05-06
HRP970383A2 (en)	1998-10-31
DK1382348T3 (da)	2006-03-13
HUP9902791A3 (en)	2000-03-28
PE84699A1 (es)	1999-11-28
NZ508939A (en)	2002-04-26
PT912194E (pt)	2004-03-31
EP0912194B1 (fr)	2003-11-05
US6818628B2 (en)	2004-11-16
HU225169B1 (en)	2006-07-28
CA2260855A1 (en)	1998-01-29
BR9710506A (pt)	1999-08-17
ATE307607T1 (de)	2005-11-15
NZ508940A (en)	2002-09-27

Publication	Publication Date	Title
FR2751229B1 (fr)	1998-11-27	Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751226B1 (fr)	1998-11-27	Formule de vaccin polynucleotidique contre les pathologies du cheval
FR2751224B1 (fr)	1998-11-20	Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
FR2751223B1 (fr)	1998-12-04	Formule de vaccin polynucleotidique felin
FR2751227B1 (fr)	1998-11-27	Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
FR2751225B1 (fr)	1998-11-27	Formule de vaccin polynucleotidique aviaire
CY2009002I1 (el)	2009-11-04	Χρηση αμινοξικων αντισπασμωδικων για τη θεραπευτικη αγωγη του πονου
PT769965E (pt)	2002-04-29	Formulacoes aquosas de risperidona
DK1031346T3 (da)	2002-08-12	Ikke-invasiv vaccination gennem huden
DE69830660D1 (de)	2005-07-28	Behandlung von atemstillstand im schlaf
FI963281A0 (fi)	1996-08-22	Ureaasipohjainen rokote ja helicobakteeri-infektion hoito
FI910413A7 (fi)	1991-07-31	Tooppiset valmisteet ihmisen kynsien hoitamiseksi
HUP0302585A3 (en)	2007-05-02	Lactic acid bacteria capable of reducing an individual's tendency to develop allerreactions
EE04179B1 (et)	2003-12-15	Liitlipiidide kasutamine stabiliseerivate lisanditena seedeensüümide segude ravimpreparaatides
ID27576A (id)	2001-04-12	Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
ITRM940396A0 (it)	1994-06-20	Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
ATE232378T1 (de)	2003-02-15	Reinigungspflaster zur verbesserung des hautzustandes
ITRM940570A0 (it)	1994-09-08	"sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
ID21948A (id)	1999-08-12	Penggunaan 1-hidroksi-2piridon untuk pengobatan infeksi-infeksi kulit
FI943974A7 (fi)	1995-03-01	Kotieläinten ihotulehdusten käsittelyvesi
ATE198751T1 (de)	2001-02-15	Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen
PL364171A1 (en)	2004-12-13	Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
ID24060A (id)	2000-07-06	Pengolahan kulit hewan yang ditingkatkan
ITMI911919A0 (it)	1991-07-11	Formulazioni orali di ubidecarenone in soluzione acquosa
ITRM940571A0 (it)	1994-09-08	"sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"